Glutaminergic Transmission in Autism : Molecular Imaging Exploration
Status:
Completed
Trial end date:
2019-05-01
Target enrollment:
Participant gender:
Summary
Glutamatergic transmission exploration using PET (Positron Emission Tomography) imaging in
autism compared to Fragile-X Syndrome ( FXS) and Healthy Volunteers